Microsoft Word - Draft MD&A_E Q3_2561_9.11.18 Management Discussion and Analysis: MD&A 1. Company Situation The company’s revenue for Q3/2018 has greatly increased compared to the revenue for Q3/2017
ขายหลักทรัพย III. KEY INFORMATION A. Selected Financial Data ขอมูลท่ีสําคัญทางการเงิน B. Capitalization and Indebtedness โครงสรางเงินทุนและและภาระผูกพัน C. Reasons for the Offer and Use of Proceeds
Comprehensive Income Revenue from Hospital Operations The Company and its subsidiary generated the total revenues from hospital operations for the 2nd quarter of the year 2016 and 2017 in amounts of Baht 280.3
compensation remuneration type, and accrued expense of the latest year’s compensation; (2) To clearly disclose the use of proceeds in each determined topic and approximately specify the amount and period of
executives’ compensation policy, method of determining the compensation packages, and structures of each compensation type;- To improve disclosure of the use of proceeds in filing documents to be more
December 31, 2015 December 31, 2014 Revenue from sales1 2,772.86 10,014.15 10,566.11 9,427.85 Total revenue 4,197.62 10,198.67 10,679.84 9,621.19 Costs and expenses 3,008.18 11,295.46 13,960.04 11,565.24
its investment in biomass powerplants to account for non-current assets held for sale. UWC plan to reinvest the proceeds in a higher return business to accommodate growth and streamline the company’s
held for sale. UWC plan to reinvest the proceeds in a higher return business to accommodate growth and streamline the company’s efficiency. PERFORMANCE OVERVIEW 2 | MANAGEMENT DISCUSSION AND ANALYSIS
purpose of Ordinary share 200,000,000 1 200,000,000 utilizing proceeds Preferred share General Mandate Ordinary share Preferred share 2/6 2. Allocation of new shares 2.1 Specify the purpose of proceeds